← Open Payments lookup

TRISH DAUPHIN: Open Payments

NPI 1740831916 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,470 in 38 payments from 14 companies in 2025. Trend: 2023 $437 · 2024 $475 · 2025 $1,470

Food & beverage: $1,470
CompanyPaymentsAmount
Gilead Sciences, Inc.13$334
ViiV Healthcare Company7$245
Dexcom, Inc.1$163
Exact Sciences Corporation4$151
Edwards Lifesciences Corporation1$125
Lilly USA, LLC1$123
GENZYME CORPORATION1$120
Alkermes, Inc.2$41
Otsuka America Pharmaceutical, Inc.2$35
Merck Sharp & Dohme LLC2$34

Products named: DEXCOM G7 GSS (161), Yeztugo, CABENUVA, MOUNJARO, FABRAZYME, The Cologuard Plus Collection Kit, APRETUDE, VIVITROL.

Industry payments across LA — which companies pay providers there.